Objectives-To determine predictors of invasiveness of lesions with US-guided biopsy-confirmed ductal carcinoma in situ (DCIS), focusing on US features, including shear wave elastography (SWE).
patients by signaling the need for further axillary lymph node sampling.
Currently, breast lesions are assessed by the Breast Imaging Reporting and Data System (BI-RADS) categories developed by the American College of Radiology, which is a widely accepted risk assessment and quality assurance tool for mammography, US, and magnetic resonance imaging. Currently, the BI-RADS assessment only estimates the overall likelihood of malignancy without distinguishing between DCIS and invasive cancer. However, several studies have shown that certain components of the BI-RADS assessment, including the size of the mass and the presence of microcalcifications, are associated with the rate of a histologic upgrade of DCIS to invasive cancer. [9] [10] [11] Other risk factors for invasiveness include high-grade DCIS, large DCIS lesions, and palpability of coexisting invasive carcinoma in patients with DCIS. 3, 4, 6, 8, 12 Some studies even recommended preoperative axillary lymph node sampling or sentinel node biopsy in patients with the aforementioned risk factors. 13, 14 In the fifth edition of the BI-RADS Atlas, elasticity of the mass was included as a new US factor within the subset of associated features. 15 In strain or shear wave elastography (SWE), the elasticity value denotes the stiffness of a mass; the stiffer the mass, the higher the probability of its being cancerous. In recent times, US has begun to be used routinely for the evaluation of tumor elasticity to distinguish between BI-RADS category 3 and 4a lesions. 16 Moreover, recent studies have demonstrated that elastographic imaging could help determine the invasiveness of DCIS. [17] [18] [19] [20] Shear wave elastography can qualitatively and quantitatively assess lesion stiffness, and it is more reproducible than strain elastography. It has been reported that quantitative stiffness values of invasive cancers are higher than those of DCIS, and high lesion stiffness values are correlated with a larger tumor size, lymph node involvement, and a high histologic grade. 21 However, there is a paucity of data regarding the independent predictive value of SWE for upgrading the histologic grade of core needle biopsy-confirmed DCIS lesions. Therefore, this study aimed to investigate imaging predictors of invasiveness in lesions with US-guided biopsyconfirmed DCIS, focusing on BI-RADS US criteria, including SWE.
Materials and Methods
Our Institutional Review Board approved this study. Informed consent from patients was not required because of the retrospective design of the study.
Patient Selection
From January 2015 to September 2016, a total of 180 breast lesions from 170 patients were diagnosed as DCIS preoperatively, according to a review of the pathology and imaging database. We excluded tumors confirmed by stereotactic biopsy (n = 27) and mammography-guided localization and excisional biopsy (n = 8) that were not visualized on US. One hundred forty-five breast lesions from 135 patients were confirmed on US-guided biopsy. We excluded 27 patients who had coexisting invasive ductal carcinoma (IDC) in the same breast or multifocal breast cancer, 20 patients who did not undergo preoperative SWE evaluations, and 15 patients who did not undergo surgery at our institution. Finally, 80 breast lesions from 78 patients were included in this analysis.
All patients underwent bilateral mammography using a full-field digital mammography system (Selenia Dimensions System; Hologic, Bedford, MA; or Senographe 2000D FFDM; GE Healthcare, Buc, France). Breast density on mammography was graded according to the BI-RADS criteria. The distribution of breast densities on mammography was as follows: grade a, 2 lesions; grade b, 14 lesions; grade c, 47 lesions; and grade d, 17 lesions. Microcalcifications were seen on mammography in 53 lesions.
Ultrasound Data Acquisition
Elastographic data were obtained by 1 of 3 radiologists with 7 to 15 years of experience in breast US using a conventional grayscale US and SWE (SuperSonic Imagine, Aix-en-Provence, France) with a 15-4-MHz linear transducer. Ultrasound-guided core needle biopsy was also performed with either a 13-gauge vacuum-assisted biopsy needle (Mammotome Elite; Devicor Medical Products, Cincinnati, OH) or a 14-gauge automated biopsy gun (Stericut; TSK Laboratory, Tochigi, Japan) immediately after Elastographic data acquisition. The same radiologist who had performed the B-mode US examination conducted the SWE study and assessed the final BI-RADS category before performing the US-guided core needle biopsy.
To obtain the SWE images, 2 orthogonal static elastographic images were obtained without compression; the sonographer then drew and stabilized a region of interest box around the lesion. Both quantitative and qualitative SWE measurements were used. Three categories of elasticity assessments according to the BI-RADS lexicon were used for qualitative color stiffness; mean and maximum elasticity values on SWE were used for quantitative measurements (Figures 1 and 2 ). 15 
Data Collection
The clinical, radiographic, and histopathologic findings of the 80 lesions were collected. Radiographic findings, including B-mode US and SWE, were assessed on the basis of real-time analysis, not retrospectively. Other data, including clinical and pathologic results, were retrospectively collected. B-mode US findings and the final assessment were classified according to the BI-RADS lexicon, 15 including shape (oval, round, or irregular), orientation (parallel or not parallel), margin (circumscribed, indistinct, angular, microlobulated, or spiculated), echo pattern (anechoic, hyperechoic, hypoechoic, isoechoic, or heterogeneous), posterior acoustic features (no posterior features, enhancement, shadowing, or a combined pattern), and associated features (architectural distortion, ductal changes, skin changes, edema, vascularity, and elasticity).
Lesion variables other than the BI-RADS lexicon, including lesion size, vascularity, mammographic findings such as microcalcifications, and biopsy variables such as the biopsy method, were retrospectively reviewed through radiology reports. The lesion size was measured as the maximal diameter by US. Lesions were divided into 2 groups based on vascularity: an internal vascularity group and an absent vascularity group. Mammographic variables included breast density, the presence of microcalcifications, the presence of a mass, and breast asymmetry.
Histopathologic results, including the nuclear grade of DCIS, were evaluated after the core needle biopsy. Additionally, the histologic type, grade, and size of the invasive component were evaluated on the basis of surgical histologic reports. A histologic upgrade to invasive cancer was defined as when lesions were diagnosed as DCIS on core needle biopsy but found to have an invasive component after surgical excision.
Statistical Analysis
For the univariate analysis, the associations among final surgical pathologic findings, clinical and histologic variables, and imaging findings of the mass were examined by an independent 2-sample t test for continuous variables, including the size of the lesion and SWE findings. The Fisher exact test was used for categorical variables, including the BI-RADS final assessment. We used a multivariate logistic regression analysis with backward elimination to assess predictors of invasiveness. We analyzed all of the variables, but only those variables that remained significant after performing the backward elimination logistic regression were reported. P < .05 was considered statistically significant. 
Results
The 78 patients included in the study ranged in age from 22 to 82 years (mean age, 53.1 years). Of the 80 lesions, 92.5% were asymptomatic; 3 cases had nipple discharge; and 3 other cases had a palpable mass. Among the 80 surgical specimens, 27 (33.8%) lesions had DCIS with an invasive component after surgical excision. Therefore, the histologic grade of about one-third of the preoperatively diagnosed DCIS lesions in this study was upgraded to invasive cancer. Detailed results of the univariate analysis of US factors are shown in Table 1 . The final BI-RADS assessment was significantly correlated with the invasiveness of the mass (P = .015). The mean and maximum stiffness values ± SD were 73.03 ± 55.74 and 85.33 ± 66.10 kPa for pure DCIS and 94.71 ± 56.64 and 119.04 ± 73.32 kPa for IDC. The maximum and mean stiffness values were lower in the pure DCIS group (P = .041 and .105, respectively). Larger masses on US imaging tended to be more likely to have an invasive component than smaller masses (P = .131), but this difference was not statistically significant. Other BI-RADS US descriptors, including shape, orientation, margin, and echogenicity, showed no significant correlation with the rate of a histologic upgrade. Table 2 shows the univariate analysis results for variables other than US factors. The nuclear grade was significantly correlated with the invasiveness of the mass (P = .005). The results showed no associations between the rate of a histologic upgrade and other clinical, mammographic, and surgical variables, such as age, breast density, and biopsy method. Two DCIS lesions diagnosed by core needle biopsy showed no residual tumor within the surgical specimen; thus, it is assumed that the DCIS foci were completely removed by the biopsy. In all, 87.5% (70 of 80) of the biopsies were performed with a 14-gauge automated biopsy gun. A total of 41% (33 of 80) of cases underwent breast-conserving surgery, and 59% (47 of 80) underwent total mastectomy. Sentinel lymph node biopsy was performed in 44% (55 of 80) of cases, and axillary lymph node dissection was performed in 5.6% (7 of 80) of cases. Among the 27 histologically upgraded cases, 2 cases showed axillary lymph node metastasis.
On the univariate analysis, the final BI-RADS assessment, maximum stiffness value on SWE, and nuclear grade were found to be significantly correlated with a histologic upgrade to microinvasive or invasive cancer. In the multivariate logistic regression analysis, the final BI-RADS assessment and histologic grade were independent predictors of a histologic upgrade, after adjusting for multiple demographic and clinical risk factors (Table 3 ). The probability of a histologic upgrade was 6 times higher in BI-RADS category 5 lesions compared with category 4a lesions (odds ratio, 6.82; P = .002) and 3 times higher in histologic grade 3 (odds ratio, 3.37; P = .041)
Discussion
This study investigated the radiographic factors associated with upgrading DCIS to IDC. The overall rate of a histologic upgrade was 33.8%. The BI-RADS category assessment based on US findings, the maximum stiffness value on SWE, and the nuclear grade of DCIS on core needle biopsy were predictive of the presence of an invasive component in DCIS based on the univariate analysis. The final BI-RADS assessment and histologic grade were independent predictors of a histologic upgrade after adjusting for multiple demographic and clinical risk factors based on the multivariate logistic regression analysis. A univariate analysis is the simplest form of data analysis when the data being analyzed contain only a single variable. The main purpose of a univariate analysis is to describe the data and find patterns that exist within the data set. Since this analysis uses a single variable, it does not provide information to suggest causes or relationships. 22 In contrast, a multivariate analysis is used to analyze 2 or more variables simultaneously and provides a way to determine the relative contributions of different causes to a single event. 22 The preoperative prediction of invasive cancer in core needle biopsy-confirmed DCIS lesions is clinically important for determining whether additional sentinel lymph node biopsy or dissection is needed. The incidence of axillary lymph node metastasis in DCIS is approximately 5% 14 ; however, the incidence increases to 10% to 20% in DCIS with invasive cancer. 9 Several previous studies have demonstrated that various factors might influence the rate of a histologic upgrade of DCIS to IDC, including palpability of the mass, the use of a 14-gauge automated biopsy device, a larger mass, a high nuclear grade, and the final BI-RADS assessment. [3] [4] [5] 8, 19 The results of this study agree with previous studies on several points, including that the final BI-RADS assessment, maximum stiffness value on SWE, and nuclear grade from a core needle biopsy are significantly associated with the rate of a histologic upgrade of DCIS to IDC. However, none of the individual factors of the BI-RADS assessment, which include mass orientation, margin, and echo pattern, were associated with the rate of a histologic upgrade.
Recently, US elastography has become widely used for estimating lesion stiffness. Moreover, SWE can both quantitatively and qualitatively assess the stiffness of a lesion during a routine breast US examination. Results have consistently shown that high-grade tumors tend to have greater stiffness on elastography. The maximum stiffness of IDC has been shown to be greater than that of DCIS in previous studies 23, 24 ; tumors tend to become stiffer as they grow because of the increase of fibrosis and decrease of necrosis.
On mammography, microcalcifications were noted in 66.3% (53 of 80) of cases in this study, and a mass or breast asymmetry was found in 28.8% (36 of 80) of cases. Contrary to the US findings, none of the mammographic findings, which included microcalcification, the presence of a mass, breast asymmetry, and breast density, showed an association with the rate of histologic upgrade from DCIS to IDC. Since this study included only US-guided biopsies, not stereotactic biopsies, it is possible that suspicious microcalcifications on mammography were not sampled. Axillary staging is generally considered to be unnecessary for DCIS patients. In this study, however, 49.6% (62 of 80) of cases underwent sentinel node biopsy (n = 55) or axillary lymph node dissection (n = 7). Among these cases, 62.9% (39 of 62) did not have an invasive component after surgery, and positive lymph node metastases were found in only 2 of the IDC cases. A high nuclear grade on core needle biopsy is also known to be associated with an invasive component on the histologic examination after surgical excision, 8 which is consistent with the findings of this study.
In our study population, most DCIS lesions (145 of 180 [80.6%]) were confirmed by US-guided biopsy. Compared with women from western countries, Asian women have breasts with higher density, and the breast cancer incidence is observed in a younger population (peak age, 40-49 years for Asia versus 60-70 years for western countries). 25 Thus, US is commonly used as an adjunctive screening tool in Asia. 25 Accordingly, in many cases of DCIS in our study, US-guided biopsies were performed.
This study had several limitations. First, the study was conducted in a single institution with a relatively small study population. Second, interobserver and intraobserver agreement was not evaluated. A single radiologist evaluated each patient without repeated readings by other radiologists. Third, our study included only US-guided core needle biopsies, not stereotactic biopsies; therefore, it is possible that suspicious microcalcifications on mammography were not sampled. Consequently, our results are not representative of US-negative lesions such as DCIS confirmed by mammography-or magnetic resonance imaging-guided biopsy. A further study that includes all patients with preoperatively diagnosed DCIS is warranted.
In conclusion, a high BI-RADS category assessment, the maximum stiffness value on SWE, and a high nuclear grade may be predictive of a histologic upgrade to invasive cancer in US-guided core needle biopsy-confirmed DCIS lesions.
